New peptide developed by Bone Sci Bio has shown in clinical trials to be effective in regeneration and integration with existing bone tissue; FDA still needs to approve

Israeli startup Bone Sci Bio Ltd. is developing a product that treats bones by promoting the formation and repair of their tissue.
The firm was set to present its new solution at the MIXiii-BIOMED 2019 Conference and Exhibition, taking place on May 14-16 at in Tel Aviv.
Read more: